Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Saborowski

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
JHEP Reports : Innovation in Hepatology|January 8, 2026
Navigating second-line therapy after immunotherapy in advanced HCC☆Arndt Vogel, Anna Saborowski, Lorenza Rimassa, et al.
Expert Review of Gastroenterology & Hepatology|May 5, 2025
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinomaXun Zhao, Talia Dufault, Gonzalo Sapisochin, et al.
Lancet (London, England)|September 9, 2022
Hepatocellular carcinomaArndt Vogel, Tim Meyer, Gonzalo Sapisochin, et al.
Cancer Treatment Reviews|January 1, 2023
Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidenceArndt Vogel, Sebastian Ochsenreither, Jonathan S Zager, et al.
Journal of Hepatology|December 17, 2022
Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinomaGajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, et al.
Hepatology (Baltimore, Md.)|December 18, 2023
Adjuvant and neoadjuvant therapies for hepatocellular carcinomaArndt Vogel, Robert C Grant, Tim Meyer, et al.
Visceral Medicine|April 9, 2025
Chemo- and Radiotherapy of Gastrointestinal Tumors during PregnancyThomas Christian Wirth, Anna Saborowski, Elna Kuehnle, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic targetAnna Saborowski, Michael Saborowski, Monika A Davare, et al.
Zeitschrift Fur Gastroenterologie|June 6, 2020
[Best supportive care in a young patient with locally advanced MSI-high colon cancer?]Sabrina Welland, Tiago De Castro, Thomas Wirth, et al.
JCO Precision Oncology|February 23, 2024
Association of RNF43 Genetic Alterations With BRAF<sup>V600E</sup> and MSI<sup>high</sup> in Colorectal CancerArndt Vogel, Karthikeyan Murugesan, Gajanan Kendre, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
JHEP Reports : Innovation in Hepatology|January 8, 2026
Navigating second-line therapy after immunotherapy in advanced HCC☆Arndt Vogel, Anna Saborowski, Lorenza Rimassa, et al.
Expert Review of Gastroenterology & Hepatology|May 5, 2025
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinomaXun Zhao, Talia Dufault, Gonzalo Sapisochin, et al.
Lancet (London, England)|September 9, 2022
Hepatocellular carcinomaArndt Vogel, Tim Meyer, Gonzalo Sapisochin, et al.
Cancer Treatment Reviews|January 1, 2023
Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidenceArndt Vogel, Sebastian Ochsenreither, Jonathan S Zager, et al.
Journal of Hepatology|December 17, 2022
Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinomaGajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, et al.
Hepatology (Baltimore, Md.)|December 18, 2023
Adjuvant and neoadjuvant therapies for hepatocellular carcinomaArndt Vogel, Robert C Grant, Tim Meyer, et al.
Visceral Medicine|April 9, 2025
Chemo- and Radiotherapy of Gastrointestinal Tumors during PregnancyThomas Christian Wirth, Anna Saborowski, Elna Kuehnle, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic targetAnna Saborowski, Michael Saborowski, Monika A Davare, et al.
Zeitschrift Fur Gastroenterologie|June 6, 2020
[Best supportive care in a young patient with locally advanced MSI-high colon cancer?]Sabrina Welland, Tiago De Castro, Thomas Wirth, et al.
JCO Precision Oncology|February 23, 2024
Association of RNF43 Genetic Alterations With BRAF<sup>V600E</sup> and MSI<sup>high</sup> in Colorectal CancerArndt Vogel, Karthikeyan Murugesan, Gajanan Kendre, et al.
Pageof 8